Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan

Director William Hoffman of Inari Medical, Inc. sold shares of common stock on May 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• William Hoffman, a director at Inari Medical, Inc., sold shares of the company's common stock on May 16, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• A total of 32,701 shares were sold at a weighted average price of $46.51, with individual trades ranging from $45.87 to $46.86.
• An additional 7,299 shares were sold at a weighted average price of $47, with individual trades ranging from $46.87 to $47.18.
• Following these transactions, Hoffman directly owns 925,359 shares of Inari Medical, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine insider selling under a pre-arranged trading plan, which doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on material non-public information.

Stakeholder Impact

• The stock sale by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates